Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination. 1988

K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
Institute for Immunology, Faculty of Medicine, Kyoto University, Japan.

In this study, we first established several CTL clones of (BALB/c x C57BL/6)F1 origin that were specific for either syngeneic UV female 1 or UV male 1 fibrosarcoma cell lines. All the CTL clones had Thy-1+ Lyt-2+ L3T4- phenotypes and showed Kd restriction when lysing the corresponding target cells. Sera obtained from syngeneic animals immunized with three CTL clones, 10B-5 for UV female 1, and CTL9 and CTL10 for UV male 1, showed specific inhibition of target cell lysis with the corresponding CTL clones. The inhibitory activities were found in sera of the majority of immunized animals. Because the inhibitory activity resides in protein A-binding fraction, mAb were produced by hybridizing spleen cells of hyperimmune animals. N1-56 was thus obtained from a mouse immunized with 10B-5 CTL clone reactive with UV female 1. N1-56 was clonotype specific, reacting with 10B-5 but not with other CTL lines or leukemia cell lines. No N1-56+ cells were detectable in thymocytes, lymph node cells, or spleen cells of either naive or UV female 1-immune CB6F1 mice. Immunoprecipitation showed that N1-56 reacts with 90,000 Mr molecules on 10B-5 CTL clone under nonreducing conditions and 45,000 Mr molecules under reducing conditions, indicating its reactivities with idiotypic determinants of TCR on the CTL clone. N1-56 inhibited lytic activity of 10B-5, but neither N1-56 nor alpha-10B-5 hyperimmune serum inhibited that of alpha-UV female 1 mixed lymphocyte tumor cell culture cells. N1-56 induced proliferation of 10B-5 without addition of Ag.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas

Related Publications

K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
October 1992, Cellular immunology,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
November 1995, The international journal of biochemistry & cell biology,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
October 1989, Immunological investigations,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
January 1993, Problemy tuberkuleza,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
February 1983, Cellular immunology,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
April 1989, Journal of immunology (Baltimore, Md. : 1950),
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
June 1989, European journal of immunology,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
December 1988, Nihon rinsho. Japanese journal of clinical medicine,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
January 1987, Cancer metastasis reviews,
K Kuribayashi, and C Tanaka, and Y Matsubayashi, and T Masuda, and H Udono, and M Abe, and E Nakayama, and H Shiku
November 1984, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!